Sepsis diagnostic market was valued at $569.49 million in 2020, and is estimated to reach $1.2 billion by 2030, growing at a CAGR of 7.8% from 2021 to 2030.
Sepsis is the bodyโs extreme response to an infection, and is a life-threatening medical emergency. Sepsis occurs when an existing infection sets off a chain reaction throughout the body. It is caused by infections that begin ย in the lungs, urinary tract, skin, or gastrointestinal system. High heart rate or low blood pressure, fever, shivering, or feeling very cold, confusion or disorientation, shortness of breath, extreme pain or discomfort, clammy, or sweaty skin are the most commonly witnessed symptoms of sepsis that can quickly progress to tissue damage, organ failure, and death if not treated promptly.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
BioMerieux SA, Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter, Inc., T2 Biosystems, Inc, Nanosphere, Inc., Hoffmann-LA Roche Ltd
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/4255
The major driving factors of sepsis diagnostic market size include increase in burden of sepsis and surge in global geriatric population. Furthermore, increase in government funding for sepsis-related research activities and rise in prevalence of infectious diseases are expected to supplement the market growth. However, high costs automated diagnostics devices are expected to impede the market growth. Furthermore, development of rapid diagnosis/point-of-care techniques for early sepsis diagnostics are expected to provide lucrative opportunities to the market players during the forecast period.ย ย On the basis of product type, the sepsis diagnostic market size is categorized into blood culture media, instruments, assay kits & reagents, and software. The blood culture media segment is expected to dominate the market throughout the forecast period, owing to increase in number of sepsis case, surge in geriatric population, high incidence of bloodstream infection, rise in the demand for rapid diagnostic techniques, and high prevalence of infection diseases. However, the instrument segment is expected to register a CAGR of 8.7% during the forecast period, owing to increaseย in reliance of patients and physicians onย laboratory testing boosts the sepsis diagnostic market growth.ย
Depending on technology, the microbiology segment dominated the market in 2020, and is expected to exhibit a prominent growth rate in sepsis diagnostic market analysis, owing to the fact that microbiology allows accurate detection and identification of microorganisms for sepsis diagnosis through the application of culture media tests.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/4255
On the basis of method, the conventional diagnostic segment dominated the market in 2020. This segment is expected to exhibit prominent growth rate, owing to cost-effectiveness of conventional diagnostics method as compared to automated diagnostic method.
By usability, the laboratory testing dominated the market in 2020. This segment is expected to exhibit a prominent growth rate, owing to the fact that lab testing has greater accuracy in comparison to POC testing while diagnosing sepsis. On the basis of pathogen, the bacterial sepsis segment accounted for a major share in the global sepsis diagnostics market in 2020. This segment is expected to exhibit a prominent growth rate, due to increase in prevalence of hospital-acquired infections, rise in cases of bacterial sepsis, and increase in number of surgical procedures.
Region wise in sepsis diagnostic industry, North America accounted for more than 8.1% of the sepsis diagnostic market share in 2020, and is expected to remain dominant throughout the sepsis diagnostic market forecast period. This was attributed to the presence of highly develop healthcare system, high adoption of innovative sepsis diagnostics technology, and advancements in the field of sepsis diagnostics. However, Asia-Pacific is projected to register the highest CAGR of 8.9% during the forecast period, owing to surge in demand for sepsis diagnostics solution in countries with high prevalence of infectious diseases, such as China and India.
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- On the basis of technique, the microbiology garnered the highest share in 2020, and is expected to remain dominant during the forecast period.
- By method, the conventional diagnostic method segment dominated the market 2020, and is expected to continue this trend during the forecast period.
- As per usability, the laboratory testing segment acquired the largest share in 2020, and is anticipated to lead in the coming years.
- By pathogen, the bacterial sepsis segment held the largest market share in 2020, and is expected to remain dominant during the forecast period.
- Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 8.9% during the forecast period.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.